Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation

REFERENCES

• Anjum, R., and J. Blenis. 2008. The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9:747–758.
   PubMed Web of Science ®Google Scholar
• Balmanno, K., S. D. Chell, A. S. Gillings, S. Hayat, and S. J. Cook. 2009. Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines. Int. J. Cancer. 125:2332–2341.
   PubMed Web of Science ®Google Scholar
• Bost, F., M. Aouadi, L. Caron, P. Even, N. Belmonte, M. Prot, C. Dani, P. Hofman, G. Pages, J. Pouyssegur, Y. Le Marchand-Brustel, and B. Binetruy. 2005. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411.
   PubMed Web of Science ®Google Scholar
• Boulton, T. G., and M. H. Cobb. 1991. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul. 2:357–371.
   PubMedGoogle Scholar
• Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb, and G. D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675.
   PubMed Web of Science ®Google Scholar
• Boulton, T. G., G. D. Yancopoulos, J. S. Gregory, C. Slaughter, C. Moomaw, J. Hsu, and M. H. Cobb. 1990. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64–67.
   PubMed Web of Science ®Google Scholar
• Bourcier, C., A. Jacquel, J. Hess, I. Peyrottes, P. Angel, P. Hofman, P. Auberger, J. Pouyssegur, and G. Pages. 2006. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res. 66:2700–2707.
   PubMedGoogle Scholar
• Campisi, J., and F. d'Adda di Fagagna. 2007. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:729–740.
   PubMed Web of Science ®Google Scholar
• Chang, F., L. S. Steelman, J. G. Shelton, J. T. Lee, P. M. Navolanic, W. L. Blalock, R. Franklin, and J. A. McCubrey. 2003. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review). Int. J. Oncol. 22:469–480.
   PubMed Web of Science ®Google Scholar
• Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271–277.
   PubMed Web of Science ®Google Scholar
• Di Benedetto, B., C. Hitz, S. M. Holter, R. Kuhn, D. M. Vogt Weisenhorn, and W. Wurst. 2007. Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain. J. Comp. Neurol. 500:542–556.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Ebisuya, M., K. Kondoh, and E. Nishida. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118:2997–3002.
   PubMed Web of Science ®Google Scholar
• Fischer, A. M., C. D. Katayama, G. Pages, J. Pouyssegur, and S. M. Hedrick. 2005. The role of Erk1 and Erk2 in multiple stages of T cell development. Immunity 23:431–443.
   PubMed Web of Science ®Google Scholar
• Fremin, C., A. Bessard, F. Ezan, L. Gailhouste, M. Regeard, J. Le Seyec, D. Gilot, G. Pages, J. Pouyssegur, S. Langouet, and G. Baffet. 2009. Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2. Hepatology 49:930–939.
   PubMed Web of Science ®Google Scholar
• Fremin, C., F. Ezan, P. Boisselier, A. Bessard, G. Pages, J. Pouyssegur, and G. Baffet. 2007. ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 45:1035–1045.
   PubMed Web of Science ®Google Scholar
• Fukunaga, R., and T. Hunter. 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1921–1933.
   PubMed Web of Science ®Google Scholar
• Giasson, E., and S. Meloche. 1995. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J. Biol. Chem. 270:5225–5231.
   PubMedGoogle Scholar
• Gonzalez, F. A., D. L. Raden, and R. J. Davis. 1991. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266:22159–22163.
   PubMed Web of Science ®Google Scholar
• Hatano, N., Y. Mori, M. Oh-hora, A. Kosugi, T. Fujikawa, N. Nakai, H. Niwa, J. Miyazaki, T. Hamaoka, and M. Ogata. 2003. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8:847–856.
   PubMed Web of Science ®Google Scholar
• Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
   Google Scholar
• Jha, K. K., S. Banga, V. Palejwala, and H. L. Ozer. 1998. SV40-mediated immortalization. Exp. Cell Res. 245:1–7.
   PubMedGoogle Scholar
• Kim, H. S., M. C. Song, I. H. Kwak, T. J. Park, and I. K. Lim. 2003. Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence. J. Biol. Chem. 278:37497–37510.
   PubMedGoogle Scholar
• Kim-Kaneyama, J., K. Nose, and M. Shibanuma. 2000. Significance of nuclear relocalization of ERK1/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts. J. Biol. Chem. 275:20685–20692.
   PubMedGoogle Scholar
• Koppen, A., R. Ait-Aissa, J. Koster, P. G. van Sluis, I. Ora, H. N. Caron, R. Volckmann, R. Versteeg, and L. J. Valentijn. 2007. Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. Eur. J. Cancer 43:2413–2422.
   PubMedGoogle Scholar
• Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608–20616.
   PubMed Web of Science ®Google Scholar
• Lefloch, R., J. Pouyssegur, and P. Lenormand. 2008. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol. Cell. Biol. 28:511–527.
   PubMed Web of Science ®Google Scholar
• Lefloch, R., J. Pouyssegur, and P. Lenormand. 2009. Total ERK1/2 activity regulates cell proliferation. Cell Cycle 8:705–711.
   PubMed Web of Science ®Google Scholar
• Leung, J. Y., G. L. Ehmann, P. H. Giangrande, and J. R. Nevins. 2008. A role for Myc in facilitating transcription activation by E2F1. Oncogene 27:4172–4179.
   PubMedGoogle Scholar
• Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• Li, J., and S. E. Johnson. 2006. ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem. Biophys. Res. Commun. 345:1425–1433.
   PubMed Web of Science ®Google Scholar
• Lips, D. J., O. F. Bueno, B. J. Wilkins, N. H. Purcell, R. A. Kaiser, J. N. Lorenz, L. Voisin, M. K. Saba-El-Leil, S. Meloche, J. Pouyssegur, G. Pages, L. J. De Windt, P. A. Doevendans, and J. D. Molkentin. 2004. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109:1938–1941.
   PubMed Web of Science ®Google Scholar
• Liu, X., S. Yan, T. Zhou, Y. Terada, and R. L. Erikson. 2004. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23:763–776.
   PubMedGoogle Scholar
• Lloyd, A. C. 2006. Distinct functions for ERKs? J. Biol. 5:13.
   PubMedGoogle Scholar
• Loonstra, A., M. Vooijs, H. B. Beverloo, B. A. Allak, E. van Drunen, R. Kanaar, A. Berns, and J. Jonkers. 2001. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 98:9209–9214.
   PubMed Web of Science ®Google Scholar
• Lorenzini, A., M. Tresini, M. Mawal-Dewan, L. Frisoni, H. Zhang, R. G. Allen, C. Sell, and V. J. Cristofalo. 2002. Role of the Raf/MEK/ERK and the PI3K/Akt(PKB) pathways in fibroblast senescence. Exp. Gerontol. 37:1149–1156.
   PubMedGoogle Scholar
• Marchi, M., A. D'Antoni, I. Formentini, R. Parra, R. Brambilla, G. M. Ratto, and M. Costa. 2008. The N-terminal domain of ERK1 accounts for the functional differences with ERK2. PLoS One 3:e3873.
   PubMedGoogle Scholar
• Massague, J. 2004. G1 cell-cycle control and cancer. Nature 432:298–306.
   PubMed Web of Science ®Google Scholar
• Mazzucchelli, C., C. Vantaggiato, A. Ciamei, S. Fasano, P. Pakhotin, W. Krezel, H. Welzl, D. P. Wolfer, G. Pages, O. Valverde, A. Marowsky, A. Porrazzo, P. C. Orban, R. Maldonado, M. U. Ehrengruber, V. Cestari, H. P. Lipp, P. F. Chapman, J. Pouyssegur, and R. Brambilla. 2002. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34:807–820.
   PubMedGoogle Scholar
• Meloche, S. 1995. Cell cycle reentry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in the G1 phase and their inactivation at the G1/S transition. J. Cell. Physiol. 163:577–588.
   PubMed Web of Science ®Google Scholar
• Meloche, S., and J. Pouyssegur. 2007. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26:3227–3239.
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., and R. J. Davis. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19:91–118.
   PubMed Web of Science ®Google Scholar
• Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 90:8424–8428.
   PubMed Web of Science ®Google Scholar
• Narita, M., S. Nunez, E. Heard, A. W. Lin, S. A. Hearn, D. L. Spector, G. J. Hannon, and S. W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703–716.
   PubMed Web of Science ®Google Scholar
• Nekrasova, T., C. Shive, Y. Gao, K. Kawamura, R. Guardia, G. Landreth, and T. G. Forsthuber. 2005. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis. J. Immunol. 175:2374–2380.
   PubMedGoogle Scholar
• Pagès, G., S. Guerin, D. Grall, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and J. Pouyssegur. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374–1377.
   PubMed Web of Science ®Google Scholar
• Papkoff, J., R. H. Chen, J. Blenis, and J. Forsman. 1994. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol. Cell. Biol. 14:463–472.
   PubMed Web of Science ®Google Scholar
• Pearson, G., F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153–183.
   PubMed Web of Science ®Google Scholar
• Raman, M., W. Chen, and M. H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100–3112.
   PubMed Web of Science ®Google Scholar
• Robbins, D. J., E. Zhen, H. Owaki, C. A. Vanderbilt, D. Ebert, T. D. Geppert, and M. H. Cobb. 1993. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J. Biol. Chem. 268:5097–5106.
   PubMed Web of Science ®Google Scholar
• Rodier, G., C. Makris, P. Coulombe, A. Scime, K. Nakayama, K. I. Nakayama, and S. Meloche. 2005. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J. Cell Biol. 168:55–66.
   PubMedGoogle Scholar
• Saba-El-Leil, M. K., F. D. Vella, B. Vernay, L. Voisin, L. Chen, N. Labrecque, S. L. Ang, and S. Meloche. 2003. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4:964–968.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., L. G. Jones, and C. A. Peterson. 1997. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol. Endocrinol. 11:2038–2047.
   PubMedGoogle Scholar
• Sears, R., F. Nuckolls, E. Haura, Y. Taya, K. Tamai, and J. R. Nevins. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501–2514.
   PubMed Web of Science ®Google Scholar
• Servant, M. J., P. Coulombe, B. Turgeon, and S. Meloche. 2000. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J. Cell Biol. 148:543–556.
   PubMed Web of Science ®Google Scholar
• Shohet, J. M., M. J. Hicks, S. E. Plon, S. M. Burlingame, S. Stuart, S. Y. Chen, M. K. Brenner, and J. G. Nuchtern. 2002. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res. 62:1123–1128.
   PubMedGoogle Scholar
• Suzuki, T., J. K-Tsuzuku, R. Ajima, T. Nakamura, Y. Yoshida, and T. Yamamoto. 2002. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev. 16:1356–1370.
   PubMed Web of Science ®Google Scholar
• Tam, P. P., and J. Rossant. 2003. Mouse embryonic chimeras: tools for studying mammalian development. Development 130:6155–6163.
   PubMed Web of Science ®Google Scholar
• Todaro, G. J., and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299–313.
   PubMed Web of Science ®Google Scholar
• Tresini, M., A. Lorenzini, L. Frisoni, R. G. Allen, and V. J. Cristofalo. 2001. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast. Exp. Cell Res. 269:287–300.
   PubMed Web of Science ®Google Scholar
• Tresini, M., A. Lorenzini, C. Torres, and V. J. Cristofalo. 2007. Modulation of replicative senescence of diploid human cells by nuclear ERK signaling. J. Biol. Chem. 282:4136–4151.
   PubMedGoogle Scholar
• Vantaggiato, C., I. Formentini, A. Bondanza, C. Bonini, L. Naldini, and R. Brambilla. 2006. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5:14.
   PubMedGoogle Scholar
• Verykokakis, M., C. Papadaki, E. Vorgia, L. Le Gallic, and G. Mavrothalassitis. 2007. The RAS-dependent ERF control of cell proliferation and differentiation is mediated by c-Myc repression. J. Biol. Chem. 282:30285–30294.
   PubMed Web of Science ®Google Scholar
• Voisin, L., C. Julien, S. Duhamel, K. Gopalbhai, I. Claveau, M. K. Saba-El-Leil, I. G. Rodrigue-Gervais, L. Gaboury, D. Lamarre, M. Basik, and S. Meloche. 2008. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. BMC Cancer 8:337.
   PubMed Web of Science ®Google Scholar
• Waskiewicz, A. J., A. Flynn, C. G. Proud, and J. A. Cooper. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1909–1920.
   PubMed Web of Science ®Google Scholar
• Waskiewicz, A. J., J. C. Johnson, B. Penn, M. Mahalingam, S. R. Kimball, and J. A. Cooper. 1999. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol. Cell. Biol. 19:1871–1880.
   PubMed Web of Science ®Google Scholar
• Wu, L., C. Timmers, B. Maiti, H. I. Saavedra, L. Sang, G. T. Chong, F. Nuckolls, P. Giangrande, F. A. Wright, S. J. Field, M. E. Greenberg, S. Orkin, J. R. Nevins, M. L. Robinson, and G. Leone. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414:457–462.
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., M. Ebisuya, F. Ashida, K. Okamoto, S. Yonehara, and E. Nishida. 2006. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16:1171–1182.
   PubMed Web of Science ®Google Scholar
• Yang, J. Y., C. S. Zong, W. Xia, H. Yamaguchi, Q. Ding, X. Xie, J. Y. Lang, C. C. Lai, C. J. Chang, W. C. Huang, H. Huang, H. P. Kuo, D. F. Lee, L. Y. Li, H. C. Lien, X. Cheng, K. J. Chang, C. D. Hsiao, F. J. Tsai, C. H. Tsai, A. A. Sahin, W. J. Muller, G. B. Mills, D. Yu, G. N. Hortobagyi, and M. C. Hung. 2008. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol. 10:138–148.
   PubMed Web of Science ®Google Scholar
• Yao, Y., W. Li, J. Wu, U. A. Germann, M. S. Su, K. Kuida, and D. M. Boucher. 2003. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc. Natl. Acad. Sci. U. S. A. 100:12759–12764.
   PubMed Web of Science ®Google Scholar
• Yasuda, T., H. Sanjo, G. Pages, Y. Kawano, H. Karasuyama, J. Pouyssegur, M. Ogata, and T. Kurosaki. 2008. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28:499–508.
   PubMed Web of Science ®Google Scholar
• Yoon, S., and R. Seger. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44.
   PubMed Web of Science ®Google Scholar
• Zeller, K. I., A. G. Jegga, B. J. Aronow, K. A. O'Donnell, and C. V. Dang. 2003. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4:R69.
   PubMed Web of Science ®Google Scholar
• Zeng, P., H. A. Wagoner, O. H. Pescovitz, and R. Steinmetz. 2005. RNA interference (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol. Ther. 4:961–967.
   PubMed Web of Science ®Google Scholar